Susceptibilities of penicillin-susceptible and -resistant strains of Streptococcus pneumoniae to RP 59500, vancomycin, erythromycin, PD 131628, sparfloxacin, temafloxacin, win 57273, ofloxacin, and ciprofloxacin.
about
Activities of a new oral streptogramin, XRP 2868, compared to those of other agents against Streptococcus pneumoniae and haemophilus speciesEfficacy and ocular penetration of sparfloxacin in experimental streptococcal endophthalmitisSusceptibilities of penicillin- and erythromycin-susceptible and -resistant pneumococci to HMR 3647 (RU 66647), a new ketolide, compared with susceptibilities to 17 other agentsPostantibiotic effect and postantibiotic sub-MIC effect of levofloxacin compared to those of ofloxacin, ciprofloxacin, erythromycin, azithromycin, and clarithromycin against 20 pneumococciStudy of comparative antipneumococcal activities of penicillin G, RP 59500, erythromycin, sparfloxacin, ciprofloxacin, and vancomycin by using time-kill methodologyAntipneumococcal activities of gemifloxacin compared to those of nine other agentsAntipneumococcal activity of ABT-773 compared to those of 10 other agents.Evaluation of T-3811ME (BMS-284756), a new des-F(6)-quinolone, for treatment of meningitis caused by penicillin-resistant Streptococcus pneumoniae in rabbits.Quinupristin-dalfopristin: an overview.Novel streptogramin antibiotics.MIC and time-kill study of activities of DU-6859a, ciprofloxacin, levofloxacin, sparfloxacin, cefotaxime, imipenem, and vancomycin against nine penicillin-susceptible and -resistant pneumococciActivities of RPR 106972 (a new oral streptogramin), cefditoren (a new oral cephalosporin), two new oxazolidinones (U-100592 and U-100766), and other oral and parenteral agents against 203 penicillin-susceptible and -resistant pneumococci.Antimicrobial resistance of Streptococcus pneumoniae recovered from outpatients in the United States during the winter months of 1994 to 1995: results of a 30-center national surveillance study.Antipneumococcal activities of RP 59500 (quinupristin-dalfopristin), penicillin G, erythromycin, and sparfloxacin determined by MIC and rapid time-kill methodologiesAntipneumococcal activities of cefpirome and cefotaxime, alone and in combination with vancomycin and teicoplanin, determined by checkerboard and time-kill methodsMIC and time-kill study of antipneumococcal activities of RPR 106972 (a new oral streptogramin), RP 59500 (quinupristin-dalfopristin), pyostacine (RP 7293), penicillin G, cefotaxime, erythromycin, and clarithromycin against 10 penicillin-susceptibleIn vitro activities of eight macrolide antibiotics and RP-59500 (quinupristin-dalfopristin) against viridans group streptococci isolated from blood of neutropenic cancer patients.Comparison of Etest to broth microdilution method for testing Streptococcus pneumoniae susceptibility to levofloxacin and three macrolides.Comparative activities of LY 333328, a new glycopeptide, against penicillin-susceptible and -resistant pneumococciTrovafloxacin, a new fluoroquinolone with potent activity against Streptococcus pneumoniae.Susceptibilities of 228 penicillin- and erythromycin-susceptible and -resistant pneumococci to RU 64004, a new ketolide, compared with susceptibilities to 16 other agents.Antipneumococcal activity of BAY 12-8039, a new quinolone, compared with activities of three other quinolones and four oral beta-lactams.Daptomycin.Antimicrobial susceptibilities and serotypes of invasive Streptococcus pneumoniae strains in Switzerland.Levofloxacin and sparfloxacin: new quinolone antibiotics.Gemifloxacin is effective in experimental pneumococcal meningitisMoxifloxacin in the therapy of experimental pneumococcal meningitis.Antipneumococcal activity of BMS 284756 compared to those of six other agents.Antipneumococcal activity of ertapenem (MK-0826) compared to those of other agents.Antipneumococcal and antistaphylococcal activities of ranbezolid (RBX 7644), a new oxazolidinone, compared to those of other agents.Quinolone antibiotics in therapy of experimental pneumococcal meningitis in rabbits.Trovafloxacin in treatment of rabbits with experimental meningitis caused by high-level penicillin-resistant Streptococcus pneumoniae.Antipneumococcal activity of LBM415, a new peptide deformylase inhibitor, compared with those of other agents.Antipneumococcal activity of DK-507k, a new quinolone, compared with the activities of 10 other agents.Comparative antipneumococcal activities of sulopenem and other drugs.Bactericidal effect of sparfloxacin alone and in combination with amoxicillin against Streptococcus pneumoniae as determined by kill-kinetic studies.
P2860
Q24564933-DB98CE2F-1850-4EB6-B178-A8425FA044C2Q28263381-04C2E6F3-C49C-4BDC-B944-0D582222066FQ33691239-5806AAD9-A706-4ACD-8220-CE1929FF341DQ33696032-16E954C9-A2B6-4578-8655-2CB7A8F2A501Q33758620-3019AE2D-900B-400A-AF4E-4727EDEBE39DQ33978679-03070219-597A-42D4-B172-57273C68DF1CQ33980037-67FA4621-9100-4AE0-9417-65F7A87D97BBQ34108423-B07EF84C-23D4-4CC7-8696-9E9E7C1FEC04Q34113774-B5838AB9-E20D-424D-80FE-44223744F892Q34141055-F4A104CA-2242-4B59-A17F-C64CA6759374Q35122364-B6980DB6-1559-482B-9E4F-52C87DA4483CQ35122591-DE5E95C0-E5DA-4034-944E-1DC177E93B74Q35124415-9E3961F5-AA15-4D29-8893-3EDE8435E3BCQ35125580-2F55F765-CCDE-4A0F-9B85-3EECAFE2D4A2Q35126435-E241D202-24EA-4F37-A7A6-55AD47F2AA4DQ35126660-2847E818-B68E-4D06-883C-1D17DE8619E3Q35126797-291522F8-5FD5-48BF-A930-A4D36CBABEF4Q35128473-78FC8F04-C9BC-43C5-B78D-603EC13DC676Q35129463-EE07678D-1010-4771-A91C-F47725FA28BAQ35133005-2E0926DA-7B92-4659-BD9C-65DA3CBC42DFQ35135982-08EA767E-B8BE-4193-8523-B63492861284Q35139557-A29B72C2-A745-4BFF-BDAD-2A045EB96E0BQ35637066-F8233771-95F6-4ADE-9BE7-2FBCA2F948B9Q36526369-E0E778F7-24CC-400F-93ED-15E5934FFD70Q37881273-A549A6B7-8162-484A-9BC3-700CF2ABE84AQ39473262-4A9D60FF-839A-442F-926F-F9D5BA8C7062Q39557705-76D4C883-D865-42BF-9479-DFA8BB857987Q39650891-EE5FBEAA-9169-4CB8-816D-9564B6A91A5DQ39650917-FA3BE63E-2437-4342-A5BC-80A61E1B93A3Q39732005-650FCC0C-7787-4190-9942-2A904B84F690Q39779290-D5BD0C3C-C52A-492A-BBB3-6866E14ABE2AQ39784239-CD8CA31A-E24F-468C-8DF7-6FC5B73975F4Q40165383-13E29FC2-D083-4F18-BD38-460CEB12C209Q40345358-1D01B61D-B33B-4B9F-9188-A39D5163240FQ43121857-09A97A7F-5125-4899-8971-E3FCE702D247Q43580576-BB86AE0D-47CD-4F1B-B79B-600C5723CAC2
P2860
Susceptibilities of penicillin-susceptible and -resistant strains of Streptococcus pneumoniae to RP 59500, vancomycin, erythromycin, PD 131628, sparfloxacin, temafloxacin, win 57273, ofloxacin, and ciprofloxacin.
description
1992 nî lūn-bûn
@nan
1992年の論文
@ja
1992年論文
@yue
1992年論文
@zh-hant
1992年論文
@zh-hk
1992年論文
@zh-mo
1992年論文
@zh-tw
1992年论文
@wuu
1992年论文
@zh
1992年论文
@zh-cn
name
Susceptibilities of penicillin ...... ofloxacin, and ciprofloxacin.
@ast
Susceptibilities of penicillin ...... ofloxacin, and ciprofloxacin.
@en
type
label
Susceptibilities of penicillin ...... ofloxacin, and ciprofloxacin.
@ast
Susceptibilities of penicillin ...... ofloxacin, and ciprofloxacin.
@en
prefLabel
Susceptibilities of penicillin ...... ofloxacin, and ciprofloxacin.
@ast
Susceptibilities of penicillin ...... ofloxacin, and ciprofloxacin.
@en
P2093
P2860
P356
P1476
Susceptibilities of penicillin ...... ofloxacin, and ciprofloxacin.
@en
P2093
M R Jacobs
P C Appelbaum
S K Spangler
P2860
P304
P356
10.1128/AAC.36.4.856
P407
P577
1992-04-01T00:00:00Z